Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Frontiers in Immunology
|
February 29, 2024
Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target
Marsha Pellegrino, Valerio Secli, Silvia D'Amico, et al.
NPJ Precision Oncology
|
August 20, 2025
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system
Alba Clara Fernández-Rilo, Emmanuel de Billy, Giada Del Baldo, et al.
Frontiers in Oncology
|
November 30, 2018
<i>BRAF</i> V600E Inhibitor (Vemurafenib) for <i>BRAF</i> V600E Mutated Low Grade Gliomas
Francesca Del Bufalo, Giulia Ceglie, Antonella Cacchione, et al.
American Journal of Medical Genetics. Part A
|
December 21, 2018
Burkitt lymphoma in a patient with Kabuki syndrome carrying a novel KMT2D mutation
Emmanuel de Billy, Luisa Strocchio, Antonella Cacchione, et al.
International Journal of Molecular Sciences
|
September 18, 2020
Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPG
Giulia Pericoli, Stefania Petrini, Ezio Giorda, et al.
NAR Cancer
|
March 16, 2026
Human DEAH-box helicase 8 regulates HSF1-mediated stress response and cancer-associated pre-mRNA splicing in tumour cells
Jennifer R Tall, Robert Te Poele, Alexandra Vasile, et al.
Cell Death and Differentiation
|
March 27, 2026
Proteasome inhibition promotes Foxn1 expression in thymic epithelial cells and induces thymic regeneration in mice
Shirley Genah, Marsha Pellegrino, Manuela Giansanti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2018
HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target
Jacqueline H L Fok, Somaieh Hedayat, Lei Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 28, 2022
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
Ilaria Romito, Manuela Porru, Maria Rita Braghini, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 17, 2021
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
Ilaria Romito, Manuela Porru, Maria Rita Braghini, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Frontiers in Immunology
|
February 29, 2024
Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target
Marsha Pellegrino, Valerio Secli, Silvia D'Amico, et al.
NPJ Precision Oncology
|
August 20, 2025
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system
Alba Clara Fernández-Rilo, Emmanuel de Billy, Giada Del Baldo, et al.
Frontiers in Oncology
|
November 30, 2018
<i>BRAF</i> V600E Inhibitor (Vemurafenib) for <i>BRAF</i> V600E Mutated Low Grade Gliomas
Francesca Del Bufalo, Giulia Ceglie, Antonella Cacchione, et al.
American Journal of Medical Genetics. Part A
|
December 21, 2018
Burkitt lymphoma in a patient with Kabuki syndrome carrying a novel KMT2D mutation
Emmanuel de Billy, Luisa Strocchio, Antonella Cacchione, et al.
International Journal of Molecular Sciences
|
September 18, 2020
Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPG
Giulia Pericoli, Stefania Petrini, Ezio Giorda, et al.
NAR Cancer
|
March 16, 2026
Human DEAH-box helicase 8 regulates HSF1-mediated stress response and cancer-associated pre-mRNA splicing in tumour cells
Jennifer R Tall, Robert Te Poele, Alexandra Vasile, et al.
Cell Death and Differentiation
|
March 27, 2026
Proteasome inhibition promotes Foxn1 expression in thymic epithelial cells and induces thymic regeneration in mice
Shirley Genah, Marsha Pellegrino, Manuela Giansanti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2018
HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target
Jacqueline H L Fok, Somaieh Hedayat, Lei Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 28, 2022
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
Ilaria Romito, Manuela Porru, Maria Rita Braghini, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 17, 2021
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
Ilaria Romito, Manuela Porru, Maria Rita Braghini, et al.
Page
of 3